This activity is expired and is no longer available for CME credit.


Understanding the Mechanisms of Action of Biologics and Immunosuppressive Drugs and Assessing their Adverse Event Profiles

Author(s)/Faculty: Grace C. Wright, MD, PhD, FACR
Release Date: 11/22/2016Expiration Date: 11/21/2019
Credit Type: CNENumber of Credits: 0
Content Type: LectureProvider:
Rheumatoid arthritis (RA) is a progressive, painful, systemic inflammatory disease that attacks the synovium of the joint, leading to joint destruction, debility, and deformity. If RA is not treated, it can cause diminished quality of life, loss of physical function, and difficulty carrying out the tasks of daily life. An increased understanding of immune-mediated pathways has led to the development of targeted RA therapies that have made significant differences in the treatment and prognosis of the disease. The introduction of biologic and other targeted therapies has changed the landscape of RA treatment and is also changing the nature of rheumatology nursing. Rheumatology nurses are challenged to keep up to date with these new and emerging therapies if they are to offer their patients care that will restore their optimal state of health and quality of life. This activity will focus on understanding the mechanisms of action of biologics and immunosuppressive drugs as well as assessing their adverse event profiles.